IQVIA
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise.
Latest IQVIA Content
Article
Strengthening a Commitment to Diversity and Inclusion in R&D With the Help of Novel Machine Learning Approaches
In this article, we discuss how a deep learning framework can specifically address real-world challenges to enhance site selection while seeking to improve trial diversity.
Article
Flexible Clinical Modeling: How Advanced Analytics and AI/ML Can Help Ensure Effective Patient-Centered Drug Development
This article explores several examples of how comprehensive modeling tools and expert guidance can help determine what specific adaptations can optimize trials.
News
Americans May Take Prescription Drugs for Around Half Their Lives
A new study examining trends in prescription drug use in the US suggests that Americans born in 2019 are expected to take prescription medications for roughly half their lives.
Article
Maximizing the Potential of Real-World Data for Evidence Generation
This article explores why the traditional process of sorting through RWD is a challenge, what value is lost through that process, and the underlying technology needed to be able to filter and sort data in a compliant manner.
News
The Relationship Between Fatherhood and Antidepressant Use
New fathers are over 30 times more likely to take antidepressants in the first year after having a child, if they have a recent history of the treatment, finds a new study.
News
ADHD Diagnoses Have Significantly Increased in the UK
Both ADHD diagnoses and prescriptions for ADHD medication have increased significantly over the past two decades, except in children under five, finds a new study by UCL researchers.
Article
Establishing the Self-Driving Clinical Trial
What does a self-driving clinical trial look like and what does it mean for the industry? Explore the ins and outs of AI in clinical development in this article.
Article
Developing the Next Generation of Inhalers
Pressurized metered dose inhalers are the dominant form of treatment for millions of asthma sufferers. But, with the need to phase out high global warming potential propellants that are currently integral to device function, what does the future look like for pMDI use?
Industry Insight
Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights
Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.
Industry Insight
Digital Twins and Trial Arms: Is the Future of Single-Arm Oncology Trials Already Here?
In this opinion piece, Dr. Gen Li discusses how AI and predictive analytics are transforming oncology clinical trials.
Advertisement
